SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Neotherapuetics possibly has a breakthrough drug - NEOT -- Ignore unavailable to you. Want to Upgrade?


To: Gerald Underwood who wrote (58)11/16/1999 2:54:00 PM
From: Gerald Underwood  Read Replies (1) | Respond to of 204
 
Institutional ownership of NEOT at
yahoo.marketguide.com



To: Gerald Underwood who wrote (58)1/18/2000 11:45:00 PM
From: Marty  Read Replies (2) | Respond to of 204
 
Here is a mention of NEOT.
siliconinvestor.com

I understand there is a more complete discussion of NEOT in NeuroInvest's current newsletter, including a prediction that a 1500 patient pivotal study will begin in April in Europe, confirmation of NEOT's lead time advantage, and a target price of 18 this year.